In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Fragrance distributor signs licensing agreement with LVMH's Celine division, Inter Parfums announces May 23. Inter Parfums will begin distributing the designer's Magic women's scent in January 2001, to be followed by two new fragrances bowing within the next 18 months, LVMH says. The French luxury goods firm owns 20.5% of Inter Parfums. The deal is the second licensing agreement between the two companies; Inter Parfums distributes LVMH's Christian Lacroix fragrances (1"The Rose Sheet" April 5, 1999, In Brief)

You may also be interested in...



Inter Parfums Celine Fragrance Launch To Bolster 2001 Sales

Inter Parfums' premiere Celine fragrances for men and women are expected to help the firm boost year-end sales 13% to $113 mil., CEO Jean Madar announced during the company's second quarter conference call Aug. 8.

Inter Parfums Celine Fragrance Launch To Bolster 2001 Sales

Inter Parfums' premiere Celine fragrances for men and women are expected to help the firm boost year-end sales 13% to $113 mil., CEO Jean Madar announced during the company's second quarter conference call Aug. 8.

Inter Parfums Prestige Launch Plan Spans Through 2002 - CEO Madar

Inter Parfums is initiating an aggressive product launch strategy over the next few years in an effort to build its $63 mil. prestige beauty care business, Chairman and CEO Jean Madar said.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel